Impaired training-induced angiogenesis process with loss of pericyte-endothelium interactions is associated with an abnormal capillary remodelling in the skeletal muscle of COPD patients.
Léo BlervaqueEmilie PasserieuxPascal PomièsMatthias CatteauNelly HéraudMarine BlaquièreFrançois BughinBronia AyoubNicolas MolinariJean-Paul CristolAntonia Perez-MartinJacques MercierMaurice HayotFares GouziPublished in: Respiratory research (2019)
Chronic obstructive pulmonary disease (COPD) is associated with exercise intolerance and limits the functional gains in response to exercise training in patients compared to sedentary healthy subjects (SHS). The blunted skeletal muscle angiogenesis previously observed in COPD patients has been linked to these limited functional improvements, but its underlying mechanisms, as well as the potential role of oxidative stress, remain poorly understood. Therefore, we compared ultrastructural indexes of angiogenic process and capillary remodelling by transmission electron microscopy in 9 COPD patients and 7 SHS after 6 weeks of individualized moderate-intensity endurance training. We also assessed oxidative stress by plasma-free and esterified isoprostane (F2-IsoP) levels in both groups. We observed a capillary basement membrane thickening in COPD patients only (p = 0.008) and abnormal variations of endothelial nucleus density in response to exercise training in these patients when compared to SHS (p = 0.042). COPD patients had significantly fewer occurrences of pericyte/endothelium interdigitations, a morphologic marker of capillary maturation, than SHS (p = 0.014), and significantly higher levels of F2-IsoP (p = 0.048). Last, the changes in pericyte/endothelium interdigitations and F2-IsoP levels in response to exercise training were negatively correlated (r = - 0.62, p = 0.025). This study is the first to show abnormal capillary remodelling and to reveal impairments during the whole process of angiogenesis (capillary creation and maturation) in COPD patients. TRIAL REGISTRATION: NCT01183039 & NCT01183052, both registered 7 August 2010 (retrospectively registered).
Keyphrases
- end stage renal disease
- chronic obstructive pulmonary disease
- skeletal muscle
- oxidative stress
- newly diagnosed
- chronic kidney disease
- ejection fraction
- type diabetes
- peritoneal dialysis
- clinical trial
- nitric oxide
- physical activity
- metabolic syndrome
- adipose tissue
- dna damage
- dna methylation
- patient reported outcomes
- endothelial cells
- blood brain barrier
- gene expression
- body composition
- diabetic rats
- genome wide
- heat shock
- climate change